Ablynx NV and Merck Serono have expanded a partnership dating from 2008 to focus on early discovery across a range of therapeutic areas with the goal of identifying antibody-derived therapeutic proteins for later stage development. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
